Welcome to our dedicated page for CLASSWOR news (Ticker: CHNO), a resource for investors and traders seeking the latest updates and insights on CLASSWOR stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CLASSWOR's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CLASSWOR's position in the market.
Classworx Inc. (OTC PINK:CHNO) has completed its first quarter audit for the period ending March 31, 2021, and filed a FORM S1 with the SEC. The audit, conducted by BF Borgers CPA, covers financials for 2019, 2020, and Q1 2021. The S1 filing includes an offering of 5 million shares at $5.00 each, aiming to raise up to $25 million for the development and marketing of Classworx.com. The company is striving for full reporting status to qualify for uplisting from the OTC Pinksheets.
Classworx Inc. (OTC PINK: CHNO) has filed its FORM S1 with the U.S. SEC, as part of its goal to become a fully reporting publicly traded company. The filing, completed on June 3, 2021, includes audited financials for 2019 and 2020. The S1 pricing is set at $5.00 per share, with a total of 5 million shares available, potentially raising $25 million for development, advertising, and marketing purposes.
The company aims to enhance its platform, Classworx.com, which connects users hosting Zoom events.
Classworx, Inc. (OTC PINK: CHNO), formerly Chill N Out Cryotherapy, has published an interview with Sam Andrus, founder of DeltaVera, discussing Delta 8 THC products and their advantages over Delta 9. The interview, conducted on May 27, 2021, is available on Classworx's YouTube channel. Classworx also announced its official name change, which is pending FINRA approval, and highlighted its mission to connect individuals offering virtual classes globally through ClassWorx.com.
Classworx, Inc. (OTC PINK: CHNO) announces two free virtual events this week. The first is an interview with Sam Andrus, founder of DeltaVera, focusing on Delta 8 THC products, scheduled for May 27 at 1:15 PM EST. The second event is a fitness ab class hosted by instructor Paul Tracey, occurring the same day at 7:00 PM EST. Both events are accessible to anyone with a Zoom account. Classworx provides a platform for virtual classes and events, aiming to connect instructors and participants globally.
Classworx, previously known as Chill N Out Cryotherapy, Inc. (OTC PINK:CHNO), has rescheduled an interview with DeltaVera's founder, Sam Andrus, to May 27, 2021, at 1:15 PM EST. This event will explore Delta 8 THC products, which are touted as less psychoactive than Delta 9 THC. Classworx provides a platform for scheduling Zoom events and interviews. The company facilitates a global network for virtual classes, emphasizing user engagement and community building.
Classworx, Inc. (OTC PINK:CHNO), formerly Chill N Out Cryotherapy, announces a live Zoom interview with Sam Andrus, founder of Deltavera, on May 25, 2021, at 1:15 PM EST. This event will explore the topic of Delta 8 products, their benefits, and the rationale behind starting Deltavera. Attendees can reserve their spots at no cost. Classworx serves as a platform for virtual instructors to host paid and free events, connecting various professionals with audiences globally, enhancing opportunities for earning income remotely.
Classworx, Inc. (OTC PINK:CHNO) is enhancing community engagement by facilitating Zoom events for individuals and businesses to share their stories. These services aim to connect CEOs, entrepreneurs, and individuals to a broader audience, potentially inspiring others. Classworx allows users to create profiles, schedule events, and offer both free and paid classes, with a seamless booking and payment process through Stripe. Founded in response to the pandemic, Classworx addresses the challenge of storytelling in a cost-effective way, ensuring diverse stories reach interested audiences.
Classworx, Inc. (OTC PINK:CHNO), formerly Chill N Out Cryotherapy, invites makeup artists and enthusiasts to join its platform for virtual classes on Zoom. Classworx offers tools such as profile creation, scheduling, marketing, and payment processing via Stripe. The service aims to enhance the visibility of makeup tutorials, which have gained popularity on social media. The company seeks to connect educators with students remotely, facilitating live interaction during classes. This initiative underscores Classworx's commitment to expanding its reach in the virtual education space.
Classworx, Inc. (OTC PINK:CHNO), formerly Chill N Out Cryotherapy, offers a platform for yoga instructors to connect with students virtually via Zoom. Instructors can create profiles showcasing their schedules, class descriptions, and link their Zoom accounts. Classworx provides marketing support, student reservation tools, and payment processing through Stripe. CEO Peter Tosto emphasizes the platform's role in facilitating connections between instructors and students globally. This initiative aims to enhance the visibility and accessibility of virtual yoga classes.
Classworx, Inc. (OTC PINK:CHNO) has published an interview with Charles Strongo, CEO of Global WholeHealth Partners (OTC PINK:GWHP), on April 26, 2021. The discussion focused on FDA-approved diagnostic tests and is available on Classworx's YouTube channel. Additionally, Classworx has officially changed its name from Chill N Out Cryotherapy, Inc. and is awaiting financial approvals. Global WholeHealth Partners aims to improve healthcare through advanced diagnostic technologies, addressing significant diseases efficiently.
FAQ